Fresenius GranuFlo Naturalyte Dry Acid Concentrate For Bicarbonate Dialysis 3.0K 2,5 Ca 0.75Mg ...
FDA Device Recall #Z-0684-2013 — Class III — November 26, 2012
Recall Summary
| Recall Number | Z-0684-2013 |
| Classification | Class III — Low risk |
| Date Initiated | November 26, 2012 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Fresenius Medical Care Holdings, Inc. |
| Location | Waltham, MA |
| Product Type | Devices |
| Quantity | 2711 units |
Product Description
Fresenius GranuFlo Naturalyte Dry Acid Concentrate For Bicarbonate Dialysis 3.0K 2,5 Ca 0.75Mg .16.5GAL Catalog Number: OFD2325-3B Product Usage: GranuFlo is indicated in the treatment of acute and chronic renal failure during the hemodialysis treatment.
Reason for Recall
GranuFlo Dry Acid Concentrate may show discoloration
Distribution Pattern
US Nationwide Distribution
Lot / Code Information
Lot Number:12PXGF002
Other Recalls from Fresenius Medical Care Holdings, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0936-2026 | Class II | 5008X CAREsystem +CLiC +CDX; | Oct 25, 2025 |
| Z-0041-2026 | Class II | Optiflux¿ High Flux E-beam Dialyzer Model Numb... | Aug 29, 2025 |
| Z-1992-2025 | Class II | 5008X HDF Hemodialysis Blood Tubing Set, 24 uni... | Apr 29, 2025 |
| Z-0801-2025 | Class II | Dialyzer Optiflux 160NRe | Dec 5, 2024 |
| Z-3124-2024 | Class II | Blood Pressure Module BPM3 TM-2917B (Spare Part... | Aug 8, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.